Trials / Completed
CompletedNCT01224769
Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders
A Retrospective Multicenter Trial on Efficacy and Toxicity of Bendamustine Alone or Associated With Rituximab, as Salvage Therapy in Patients With Chronic Lymphoproliferative Disorders
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 109 (actual)
- Sponsor
- Gruppo Italiano Studio Linfomi · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This retrospective study collects and evaluates the clinical experience reached in Italy on the use of bendamustine alone or combined with rituximab as treatment of patients with relapsed or refractory chronic lymphoproliferative disorders.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bendamustine +/- rituximab |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2010-10-20
- Last updated
- 2010-10-21
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01224769. Inclusion in this directory is not an endorsement.